Industry Solution

Biotechnology

Data Integrity at Biological Scale.

Biotech operations from cell culture to GMP batch documentation demand the highest standard of data integrity. VALITRACE delivers contemporaneous, verifiable logging for every step of biological manufacturing.

21 CFR PART 11 EU GMP ANNEX 11 GAMP 5 ALCOA+

The Pain Points

Where biotech logging fails

Biological processes have no tolerance for documentation gaps.

01

Bioreactor Log Gaps

Time-critical entries every 1-4 hours often get delayed by manual transcription, especially on night shifts.

02

Multi-Step Batch Complexity

Upstream, downstream, and QC teams use different formats, making release review slow and fragmented.

03

Patient-Lot Traceability

Cell therapy manufacturers need unbroken donor-to-patient traceability where even a single gap can disqualify a lot.

04

Evolving Regulatory Landscape

Advanced therapy regulations evolve fast, while static paper templates cannot keep up.

05

Scale-Up Documentation Risk

Processes that worked at low volume often collapse when moving toward commercial scale.

06

Validation Burden

Early-stage biotech teams struggle to validate large enterprise systems quickly enough for clinical timelines.

How VALITRACE Helps

Built for the precision biologics demand

From startup GMP to multi-product commercial biologics, VALITRACE scales with you.

Process Logging

Bioreactor & Cell Culture

Contemporaneous bioreactor and cell culture logging with zero gaps

Configure time-triggered prompts for critical parameters. Missed entries trigger escalation and maintain accountability across shifts.

  • Automated prompts at configurable intervals
  • Missed entry escalation path
  • Sensor integration with operator verification
  • Complete overnight shift coverage

Batch Record System

Upstream to Release

One unified batch record from inoculation to lot release

Link upstream, downstream, and QC records into one navigable batch view with electronic review and sign-off.

  • Cross-step process traceability
  • QA electronic review and approvals
  • Automated OOS flagging
  • Submission-ready audit trail

Patient-Lot Traceability

Cell & Gene Therapy

Unbroken chain of identity from donor to patient

Maintain continuous identity tracking across processing and QC steps for autologous and allogeneic therapies.

  • Donor-to-patient identity chain
  • Chain-of-custody with sign-off
  • Deviation linkage without traceability loss
  • Part 1271 aligned documentation

Fast Validation

GAMP 5 Validated

Go validated in weeks, not many months

Deploy with IQ/OQ/PQ packages and a validation support model tuned for clinical-stage biotech timelines.

  • Pre-built GAMP 5 package
  • Dedicated validation support
  • 4-6 week typical go-live
  • Regulatory submission support

Expected Outcomes

What biotech teams achieve with VALITRACE

100%

Contemporaneous entry compliance across shifts

65%

Reduction in batch release review time

4 wks

Validated deployment for early-stage GMP sites

0 gaps

Overnight monitoring data gaps after deployment

Compliance Coverage

21 CFR PART 11 EU GMP ANNEX 11 GAMP 5 ALCOA+

Biological manufacturing sits at the intersection of stringent regulations. VALITRACE is engineered to exceed those standards by design.

Scaling from clinical to commercial?

VALITRACE grows with your biologics operation from a single GMP suite to a multi-site commercial facility.

See All Features

BOOK A DEMO

Tell us how to reach you. We will get back to you within one to two business days.